nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—acquired immunodeficiency syndrome—sarcoma	0.858	1	CtDrD
Abacavir—UGT1A1—Etoposide—sarcoma	0.0565	1	CbGbCtD
Abacavir—ADH6—liver—sarcoma	0.00152	0.153	CbGeAlD
Abacavir—ADK—mammary gland—sarcoma	0.00111	0.113	CbGeAlD
Abacavir—ADK—myometrium—sarcoma	0.000791	0.0799	CbGeAlD
Abacavir—ADK—seminal vesicle—sarcoma	0.000714	0.0722	CbGeAlD
Abacavir—ADK—hematopoietic system—sarcoma	0.000679	0.0686	CbGeAlD
Abacavir—UGT1A1—hematopoietic system—sarcoma	0.00067	0.0677	CbGeAlD
Abacavir—ADK—smooth muscle tissue—sarcoma	0.000598	0.0605	CbGeAlD
Abacavir—ADK—skin of body—sarcoma	0.00059	0.0597	CbGeAlD
Abacavir—ADK—cardiac atrium—sarcoma	0.000515	0.0521	CbGeAlD
Abacavir—ADK—lymphoid tissue—sarcoma	0.000478	0.0483	CbGeAlD
Abacavir—ADK—tendon—sarcoma	0.000449	0.0454	CbGeAlD
Abacavir—ADK—bone marrow—sarcoma	0.000435	0.044	CbGeAlD
Abacavir—ADK—testis—sarcoma	0.000372	0.0376	CbGeAlD
Abacavir—ADK—liver—sarcoma	0.000352	0.0356	CbGeAlD
Abacavir—UGT1A1—liver—sarcoma	0.000347	0.0351	CbGeAlD
Abacavir—ADK—lymph node—sarcoma	0.00027	0.0273	CbGeAlD
Abacavir—Thrombocytopenia—Mitoxantrone—sarcoma	0.000162	0.00213	CcSEcCtD
Abacavir—Anorexia—Vincristine—sarcoma	0.000162	0.00213	CcSEcCtD
Abacavir—Hepatic failure—Doxorubicin—sarcoma	0.000162	0.00213	CcSEcCtD
Abacavir—Skin disorder—Mitoxantrone—sarcoma	0.000161	0.00211	CcSEcCtD
Abacavir—Lethargy—Epirubicin—sarcoma	0.00016	0.00211	CcSEcCtD
Abacavir—Hypotension—Vincristine—sarcoma	0.000159	0.00209	CcSEcCtD
Abacavir—Feeling abnormal—Thiotepa—sarcoma	0.000158	0.00208	CcSEcCtD
Abacavir—Anorexia—Mitoxantrone—sarcoma	0.000158	0.00207	CcSEcCtD
Abacavir—Feeling abnormal—Dactinomycin—sarcoma	0.000157	0.00206	CcSEcCtD
Abacavir—Gastrointestinal pain—Thiotepa—sarcoma	0.000157	0.00206	CcSEcCtD
Abacavir—Ill-defined disorder—Etoposide—sarcoma	0.000157	0.00206	CcSEcCtD
Abacavir—Anaemia—Etoposide—sarcoma	0.000156	0.00205	CcSEcCtD
Abacavir—Gastrointestinal pain—Dactinomycin—sarcoma	0.000156	0.00205	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Vincristine—sarcoma	0.000155	0.00204	CcSEcCtD
Abacavir—Hypotension—Mitoxantrone—sarcoma	0.000155	0.00203	CcSEcCtD
Abacavir—Migraine—Epirubicin—sarcoma	0.000155	0.00203	CcSEcCtD
Abacavir—Insomnia—Vincristine—sarcoma	0.000154	0.00202	CcSEcCtD
Abacavir—Paraesthesia—Vincristine—sarcoma	0.000153	0.00201	CcSEcCtD
Abacavir—Urticaria—Thiotepa—sarcoma	0.000152	0.002	CcSEcCtD
Abacavir—Malaise—Etoposide—sarcoma	0.000152	0.002	CcSEcCtD
Abacavir—Vertigo—Etoposide—sarcoma	0.000152	0.00199	CcSEcCtD
Abacavir—Abdominal pain—Thiotepa—sarcoma	0.000152	0.00199	CcSEcCtD
Abacavir—Body temperature increased—Thiotepa—sarcoma	0.000152	0.00199	CcSEcCtD
Abacavir—Leukopenia—Etoposide—sarcoma	0.000151	0.00199	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000151	0.00198	CcSEcCtD
Abacavir—Abdominal pain—Dactinomycin—sarcoma	0.00015	0.00198	CcSEcCtD
Abacavir—Body temperature increased—Dactinomycin—sarcoma	0.00015	0.00198	CcSEcCtD
Abacavir—Paraesthesia—Mitoxantrone—sarcoma	0.000149	0.00195	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—sarcoma	0.000148	0.00195	CcSEcCtD
Abacavir—Decreased appetite—Vincristine—sarcoma	0.000148	0.00194	CcSEcCtD
Abacavir—Dyspnoea—Mitoxantrone—sarcoma	0.000148	0.00194	CcSEcCtD
Abacavir—Cough—Etoposide—sarcoma	0.000147	0.00194	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—sarcoma	0.000147	0.00193	CcSEcCtD
Abacavir—Gastrointestinal disorder—Vincristine—sarcoma	0.000147	0.00193	CcSEcCtD
Abacavir—Fatigue—Vincristine—sarcoma	0.000147	0.00193	CcSEcCtD
Abacavir—Convulsion—Etoposide—sarcoma	0.000146	0.00192	CcSEcCtD
Abacavir—Pain—Vincristine—sarcoma	0.000145	0.00191	CcSEcCtD
Abacavir—Liver function test abnormal—Epirubicin—sarcoma	0.000145	0.00191	CcSEcCtD
Abacavir—Decreased appetite—Mitoxantrone—sarcoma	0.000144	0.00189	CcSEcCtD
Abacavir—Abdominal pain upper—Epirubicin—sarcoma	0.000144	0.00189	CcSEcCtD
Abacavir—Migraine—Doxorubicin—sarcoma	0.000143	0.00188	CcSEcCtD
Abacavir—Fatigue—Mitoxantrone—sarcoma	0.000143	0.00188	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000143	0.00188	CcSEcCtD
Abacavir—Discomfort—Etoposide—sarcoma	0.000142	0.00187	CcSEcCtD
Abacavir—Pain—Mitoxantrone—sarcoma	0.000142	0.00186	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000142	0.00186	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000142	0.00186	CcSEcCtD
Abacavir—Hypersensitivity—Thiotepa—sarcoma	0.000141	0.00186	CcSEcCtD
Abacavir—Hypersensitivity—Dactinomycin—sarcoma	0.00014	0.00184	CcSEcCtD
Abacavir—Gastrointestinal pain—Vincristine—sarcoma	0.000139	0.00183	CcSEcCtD
Abacavir—Gastritis—Epirubicin—sarcoma	0.000139	0.00183	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000139	0.00182	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—sarcoma	0.000139	0.00182	CcSEcCtD
Abacavir—Anaphylactic shock—Etoposide—sarcoma	0.000138	0.00181	CcSEcCtD
Abacavir—Asthenia—Thiotepa—sarcoma	0.000138	0.00181	CcSEcCtD
Abacavir—Infection—Etoposide—sarcoma	0.000137	0.0018	CcSEcCtD
Abacavir—Asthenia—Dactinomycin—sarcoma	0.000137	0.00179	CcSEcCtD
Abacavir—Feeling abnormal—Mitoxantrone—sarcoma	0.000137	0.00179	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—sarcoma	0.000136	0.00179	CcSEcCtD
Abacavir—Pruritus—Thiotepa—sarcoma	0.000136	0.00178	CcSEcCtD
Abacavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000135	0.00178	CcSEcCtD
Abacavir—Thrombocytopenia—Etoposide—sarcoma	0.000135	0.00177	CcSEcCtD
Abacavir—Abdominal pain—Vincristine—sarcoma	0.000134	0.00177	CcSEcCtD
Abacavir—Body temperature increased—Vincristine—sarcoma	0.000134	0.00177	CcSEcCtD
Abacavir—Liver function test abnormal—Doxorubicin—sarcoma	0.000134	0.00176	CcSEcCtD
Abacavir—Skin disorder—Etoposide—sarcoma	0.000134	0.00176	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—sarcoma	0.000133	0.00175	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—sarcoma	0.000133	0.00175	CcSEcCtD
Abacavir—Urticaria—Mitoxantrone—sarcoma	0.000132	0.00173	CcSEcCtD
Abacavir—Anorexia—Etoposide—sarcoma	0.000131	0.00173	CcSEcCtD
Abacavir—Diarrhoea—Thiotepa—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Body temperature increased—Mitoxantrone—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Abdominal pain—Mitoxantrone—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—sarcoma	0.000131	0.00172	CcSEcCtD
Abacavir—Diarrhoea—Dactinomycin—sarcoma	0.00013	0.00171	CcSEcCtD
Abacavir—Hypotension—Etoposide—sarcoma	0.000129	0.00169	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—sarcoma	0.000129	0.00169	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—sarcoma	0.000128	0.00169	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000128	0.00169	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—sarcoma	0.000127	0.00167	CcSEcCtD
Abacavir—Dizziness—Thiotepa—sarcoma	0.000127	0.00167	CcSEcCtD
Abacavir—Hypersensitivity—Vincristine—sarcoma	0.000125	0.00165	CcSEcCtD
Abacavir—Paraesthesia—Etoposide—sarcoma	0.000124	0.00163	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—sarcoma	0.000123	0.00162	CcSEcCtD
Abacavir—Dyspnoea—Etoposide—sarcoma	0.000123	0.00161	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—sarcoma	0.000123	0.00161	CcSEcCtD
Abacavir—Hypersensitivity—Mitoxantrone—sarcoma	0.000122	0.0016	CcSEcCtD
Abacavir—Asthenia—Vincristine—sarcoma	0.000122	0.0016	CcSEcCtD
Abacavir—Vomiting—Thiotepa—sarcoma	0.000122	0.0016	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—sarcoma	0.000122	0.0016	CcSEcCtD
Abacavir—Vomiting—Dactinomycin—sarcoma	0.000121	0.00159	CcSEcCtD
Abacavir—Rash—Thiotepa—sarcoma	0.000121	0.00159	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—sarcoma	0.000121	0.00159	CcSEcCtD
Abacavir—Dermatitis—Thiotepa—sarcoma	0.000121	0.00159	CcSEcCtD
Abacavir—Headache—Thiotepa—sarcoma	0.00012	0.00158	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00012	0.00158	CcSEcCtD
Abacavir—Rash—Dactinomycin—sarcoma	0.00012	0.00158	CcSEcCtD
Abacavir—Decreased appetite—Etoposide—sarcoma	0.00012	0.00157	CcSEcCtD
Abacavir—Renal failure—Epirubicin—sarcoma	0.000119	0.00156	CcSEcCtD
Abacavir—Gastrointestinal disorder—Etoposide—sarcoma	0.000119	0.00156	CcSEcCtD
Abacavir—Asthenia—Mitoxantrone—sarcoma	0.000119	0.00156	CcSEcCtD
Abacavir—Fatigue—Etoposide—sarcoma	0.000119	0.00156	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—sarcoma	0.000119	0.00156	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—sarcoma	0.000118	0.00155	CcSEcCtD
Abacavir—Pain—Etoposide—sarcoma	0.000118	0.00155	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—sarcoma	0.000118	0.00155	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—sarcoma	0.000118	0.00154	CcSEcCtD
Abacavir—Diarrhoea—Vincristine—sarcoma	0.000116	0.00153	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—sarcoma	0.000115	0.00151	CcSEcCtD
Abacavir—Nausea—Thiotepa—sarcoma	0.000114	0.0015	CcSEcCtD
Abacavir—Feeling abnormal—Etoposide—sarcoma	0.000114	0.00149	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—sarcoma	0.000113	0.00149	CcSEcCtD
Abacavir—Diarrhoea—Mitoxantrone—sarcoma	0.000113	0.00149	CcSEcCtD
Abacavir—Nausea—Dactinomycin—sarcoma	0.000113	0.00149	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—sarcoma	0.000113	0.00148	CcSEcCtD
Abacavir—Gastrointestinal pain—Etoposide—sarcoma	0.000113	0.00148	CcSEcCtD
Abacavir—Dizziness—Vincristine—sarcoma	0.000112	0.00148	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000111	0.00146	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—sarcoma	0.00011	0.00145	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—sarcoma	0.00011	0.00144	CcSEcCtD
Abacavir—Urticaria—Etoposide—sarcoma	0.000109	0.00144	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—sarcoma	0.000109	0.00144	CcSEcCtD
Abacavir—Body temperature increased—Etoposide—sarcoma	0.000109	0.00143	CcSEcCtD
Abacavir—Abdominal pain—Etoposide—sarcoma	0.000109	0.00143	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—sarcoma	0.000109	0.00143	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—sarcoma	0.000109	0.00143	CcSEcCtD
Abacavir—Vomiting—Vincristine—sarcoma	0.000108	0.00142	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—sarcoma	0.000108	0.00142	CcSEcCtD
Abacavir—Rash—Vincristine—sarcoma	0.000107	0.00141	CcSEcCtD
Abacavir—Dermatitis—Vincristine—sarcoma	0.000107	0.00141	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—sarcoma	0.000107	0.0014	CcSEcCtD
Abacavir—Headache—Vincristine—sarcoma	0.000107	0.0014	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000106	0.00139	CcSEcCtD
Abacavir—Vomiting—Mitoxantrone—sarcoma	0.000105	0.00138	CcSEcCtD
Abacavir—Rash—Mitoxantrone—sarcoma	0.000104	0.00137	CcSEcCtD
Abacavir—Dermatitis—Mitoxantrone—sarcoma	0.000104	0.00137	CcSEcCtD
Abacavir—Headache—Mitoxantrone—sarcoma	0.000104	0.00136	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—sarcoma	0.000103	0.00135	CcSEcCtD
Abacavir—Hypersensitivity—Etoposide—sarcoma	0.000102	0.00133	CcSEcCtD
Abacavir—Nausea—Vincristine—sarcoma	0.000101	0.00133	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—sarcoma	0.000101	0.00132	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—sarcoma	9.98e-05	0.00131	CcSEcCtD
Abacavir—Asthenia—Etoposide—sarcoma	9.89e-05	0.0013	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—sarcoma	9.88e-05	0.0013	CcSEcCtD
Abacavir—Nausea—Mitoxantrone—sarcoma	9.84e-05	0.00129	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—sarcoma	9.82e-05	0.00129	CcSEcCtD
Abacavir—Chills—Epirubicin—sarcoma	9.75e-05	0.00128	CcSEcCtD
Abacavir—Pruritus—Etoposide—sarcoma	9.75e-05	0.00128	CcSEcCtD
Abacavir—Alopecia—Epirubicin—sarcoma	9.61e-05	0.00126	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—sarcoma	9.51e-05	0.00125	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—sarcoma	9.46e-05	0.00124	CcSEcCtD
Abacavir—Diarrhoea—Etoposide—sarcoma	9.43e-05	0.00124	CcSEcCtD
Abacavir—Dizziness—Etoposide—sarcoma	9.11e-05	0.0012	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—sarcoma	9.09e-05	0.00119	CcSEcCtD
Abacavir—Chills—Doxorubicin—sarcoma	9.03e-05	0.00119	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—sarcoma	8.89e-05	0.00117	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—sarcoma	8.78e-05	0.00115	CcSEcCtD
Abacavir—Vomiting—Etoposide—sarcoma	8.76e-05	0.00115	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—sarcoma	8.76e-05	0.00115	CcSEcCtD
Abacavir—Anaemia—Epirubicin—sarcoma	8.75e-05	0.00115	CcSEcCtD
Abacavir—Rash—Etoposide—sarcoma	8.69e-05	0.00114	CcSEcCtD
Abacavir—Dermatitis—Etoposide—sarcoma	8.68e-05	0.00114	CcSEcCtD
Abacavir—Headache—Etoposide—sarcoma	8.63e-05	0.00113	CcSEcCtD
Abacavir—Malaise—Epirubicin—sarcoma	8.53e-05	0.00112	CcSEcCtD
Abacavir—Vertigo—Epirubicin—sarcoma	8.5e-05	0.00112	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—sarcoma	8.47e-05	0.00111	CcSEcCtD
Abacavir—Cough—Epirubicin—sarcoma	8.26e-05	0.00109	CcSEcCtD
Abacavir—Convulsion—Epirubicin—sarcoma	8.2e-05	0.00108	CcSEcCtD
Abacavir—Nausea—Etoposide—sarcoma	8.18e-05	0.00108	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—sarcoma	8.12e-05	0.00107	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—sarcoma	8.09e-05	0.00106	CcSEcCtD
Abacavir—Myalgia—Epirubicin—sarcoma	8.06e-05	0.00106	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—sarcoma	8.06e-05	0.00106	CcSEcCtD
Abacavir—Anxiety—Epirubicin—sarcoma	8.03e-05	0.00106	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	8e-05	0.00105	CcSEcCtD
Abacavir—Discomfort—Epirubicin—sarcoma	7.96e-05	0.00105	CcSEcCtD
Abacavir—Malaise—Doxorubicin—sarcoma	7.9e-05	0.00104	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—sarcoma	7.87e-05	0.00103	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—sarcoma	7.84e-05	0.00103	CcSEcCtD
Abacavir—Oedema—Epirubicin—sarcoma	7.72e-05	0.00101	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—sarcoma	7.72e-05	0.00101	CcSEcCtD
Abacavir—Infection—Epirubicin—sarcoma	7.67e-05	0.00101	CcSEcCtD
Abacavir—Cough—Doxorubicin—sarcoma	7.64e-05	0.001	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—sarcoma	7.59e-05	0.000997	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—sarcoma	7.57e-05	0.000995	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—sarcoma	7.56e-05	0.000994	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—sarcoma	7.5e-05	0.000986	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—sarcoma	7.45e-05	0.00098	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—sarcoma	7.45e-05	0.00098	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—sarcoma	7.43e-05	0.000976	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	7.4e-05	0.000973	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—sarcoma	7.37e-05	0.000968	CcSEcCtD
Abacavir—Anorexia—Epirubicin—sarcoma	7.36e-05	0.000967	CcSEcCtD
Abacavir—Hypotension—Epirubicin—sarcoma	7.22e-05	0.000948	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—sarcoma	7.15e-05	0.000939	CcSEcCtD
Abacavir—Oedema—Doxorubicin—sarcoma	7.15e-05	0.000939	CcSEcCtD
Abacavir—Infection—Doxorubicin—sarcoma	7.1e-05	0.000933	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—sarcoma	7.04e-05	0.000925	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—sarcoma	7.01e-05	0.000921	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—sarcoma	7e-05	0.000919	CcSEcCtD
Abacavir—Insomnia—Epirubicin—sarcoma	6.99e-05	0.000918	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—sarcoma	6.94e-05	0.000912	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—sarcoma	6.94e-05	0.000911	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—sarcoma	6.89e-05	0.000905	CcSEcCtD
Abacavir—Anorexia—Doxorubicin—sarcoma	6.81e-05	0.000895	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—sarcoma	6.71e-05	0.000882	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—sarcoma	6.68e-05	0.000878	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—sarcoma	6.67e-05	0.000876	CcSEcCtD
Abacavir—Fatigue—Epirubicin—sarcoma	6.66e-05	0.000875	CcSEcCtD
Abacavir—Pain—Epirubicin—sarcoma	6.6e-05	0.000868	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.51e-05	0.000856	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—sarcoma	6.46e-05	0.000849	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—sarcoma	6.42e-05	0.000843	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—sarcoma	6.37e-05	0.000837	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—sarcoma	6.36e-05	0.000836	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—sarcoma	6.32e-05	0.00083	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—sarcoma	6.21e-05	0.000816	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—sarcoma	6.17e-05	0.000811	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—sarcoma	6.16e-05	0.00081	CcSEcCtD
Abacavir—Urticaria—Epirubicin—sarcoma	6.14e-05	0.000806	CcSEcCtD
Abacavir—Pain—Doxorubicin—sarcoma	6.11e-05	0.000803	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—sarcoma	6.11e-05	0.000802	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—sarcoma	6.11e-05	0.000802	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—sarcoma	5.89e-05	0.000774	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—sarcoma	5.84e-05	0.000768	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—sarcoma	5.69e-05	0.000748	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—sarcoma	5.68e-05	0.000746	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—sarcoma	5.65e-05	0.000742	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—sarcoma	5.65e-05	0.000742	CcSEcCtD
Abacavir—Asthenia—Epirubicin—sarcoma	5.54e-05	0.000728	CcSEcCtD
Abacavir—Pruritus—Epirubicin—sarcoma	5.46e-05	0.000718	CcSEcCtD
Abacavir—Diarrhoea—Epirubicin—sarcoma	5.28e-05	0.000694	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—sarcoma	5.27e-05	0.000692	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—sarcoma	5.13e-05	0.000674	CcSEcCtD
Abacavir—Dizziness—Epirubicin—sarcoma	5.11e-05	0.000671	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—sarcoma	5.06e-05	0.000664	CcSEcCtD
Abacavir—Vomiting—Epirubicin—sarcoma	4.91e-05	0.000645	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—sarcoma	4.89e-05	0.000643	CcSEcCtD
Abacavir—Rash—Epirubicin—sarcoma	4.87e-05	0.00064	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—sarcoma	4.87e-05	0.000639	CcSEcCtD
Abacavir—Headache—Epirubicin—sarcoma	4.84e-05	0.000636	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—sarcoma	4.73e-05	0.000621	CcSEcCtD
Abacavir—Nausea—Epirubicin—sarcoma	4.59e-05	0.000603	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—sarcoma	4.54e-05	0.000597	CcSEcCtD
Abacavir—Rash—Doxorubicin—sarcoma	4.51e-05	0.000592	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—sarcoma	4.5e-05	0.000592	CcSEcCtD
Abacavir—Headache—Doxorubicin—sarcoma	4.48e-05	0.000588	CcSEcCtD
Abacavir—Nausea—Doxorubicin—sarcoma	4.24e-05	0.000558	CcSEcCtD
